Delivery Order HHSO100201300005I-HHSO10033002T
Award Date
9/30/13
Potential Completion Date
1/26/19
Potential Value
$14M
Awardee
Partner Therapeutics, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bridgewater, NJ 08807, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amgen USA Inc., a division of the biotechnology company Amgen, by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract, valued at $37,675,456.54, is for the acquisition of a colony stimulating factor, either G-CSF or GM-CSF, to mitigate neutropenia arising from exposure to ionizing radiation. This is a delivery order contract under the HHS Colony Stimulating Factor 2013-2018 IDIQ contract, a...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Peprotech Inc., a biotechnology company that develops and manufactures cytokine products. The $3,560.00 Firm Fixed Price Purchase Order is for the delivery of recombinant human M-CSF 250 ug, a biological reagent material used in research. Peprotech Inc. has received several prior awards from the Department of Health and Human Services (HHS), National Institutes of Health (NIH), and other...
This is a Cost Plus Fixed Fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS). The $34,063,212 contract is for Clinical Trial Planning and Execution (CTPE) services, which will support the development of medical countermeasures such as vaccines, therapeutics, and other products to address infectious diseases, chemical/biological threats, and public health...
This federal contract award, with an ID of 47QRAA18D0004|75A50123F80005, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Tunnell Consulting Inc., doing business as KW Tunnell Federal Services Group, a subsidiary of K W Tunnell Company Inc. The contract, valued at $92,939,860.37, is for the provision of advanced professional scientific subject matter...
<p>This is a $632,469.60 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Biopartners, Inc. The contract supports the Tissue Source Site for Tumor Analysis program and has a final completion date of September 4, 2021. There was no set-aside designation for this award. The contract does not mention any major subcontractors.</p>
This federal contract award is a delivery order under the Medical Countermeasures Clinical Studies Network contract vehicle, which is managed by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency. The prime contractor is Technical Resources International, Inc. (dba Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business that provides clinical trials execution, regulatory support, research operations,...
This is a $7,215 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Peprotech Inc. on May 18, 2012. The contract is for the delivery of biological and reagent materials such as recombinant human growth factors and cytokines to support NIAID's research efforts. Peprotech Inc. is a privately-owned biotechnology company that develops and manufactures cytokine products....
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Palladian Partners, Inc., a for-profit organization specializing in health and science communications. The contract, valued at $3,704,171.75, is for research and development in the biomedical field, specifically basic research. It is a definitive, firm fixed-price contract with a completion date of April 26, 2017....
This contract award to Peprotech Inc., a biotechnology company that develops and manufactures cytokines, was made by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services. The $39,762 firm-fixed-price purchase order is for the delivery of various biological reagents and materials, such as recombinant human growth factors and cytokines, to support NIA's research efforts. This award is not associated with a set-aside designation. Additionally, Peprotech...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services, to Hospira Worldwide LLC, a subsidiary of the pharmaceutical company Pfizer Inc. The contract, valued at $28,913,670.44, is for the delivery of pharmaceuticals and medical supplies, including sterile injectables, antibiotics, anesthetics, and other drugs and solutions. The contract does not have a set-aside...